Vanguard Group’s Rentokil RTO Stock Holding History

Vanguard Group’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,481	Closed	-$1.15M	–	4574
2022 Q4	$1.15M	Buy	+37,481	New	+$1.16M	﹤0.01%	3859

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Vanguard Group's RTO Position: Q1 2023 in Review

Vanguard Group sold out of Rentokil (RTO) in Q1 2023, closing a stake of 37,481 shares — an estimated $1.15M sold.

Vanguard Group first reported a position in RTO in Q4 2022 and held it in 1 quarter. The position peaked at $1.15M in Q4 2022. 191 funds tracked by Wall St. Rank hold RTO as of Q1 2023.

Vanguard Group reported no remaining Rentokil position as of Q1 2023 after selling out during the quarter.
Vanguard Group sold 37,481 Rentokil shares in Q1 2023, an estimated $1.15M.
Vanguard Group first reported a position in Rentokil in Q4 2022 and held it in 1 quarter.
Vanguard Group's Rentokil position peaked at $1.15M in Q4 2022.
191 funds tracked by Wall St. Rank held Rentokil as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.